Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Merck KGaA Appoints Jasper Bos as Managing Director of M Ventures - Ink World Magazine

What are you searching for?

Sign in
Flexible Electronics News

Merck KGaA Appoints Jasper Bos as Managing Director of M Ventures

M Ventures is company’s strategic corporate venture capital arm.

Author Image

By: DAVID SAVASTANO

Contributing Editor, Coatings World and Ink World, Coatings World and Ink World Magazine

Merck KGaA, Darmstadt, Germany, announced the appointment of Jasper Bos as the new managing director of its strategic corporate venture capital arm M Ventures. He will follow Roel Bulthuis as the SVP and managing director of M Ventures. Bulthuis will be leaving the fund at the end of the year.
 
“We thank Roel for his immense contribution in building M Ventures as a leading corporate venture fund and wish him all the best for his future endeavors,” said Isabel De Paoli, chief strategy officer at Merck KGaA. “M Ventures is an important strategic lever in our ambitions to push the edge of science and technology. We are glad to be able to fill the role with an internal talent and experienced investor. Jasper Bos has been with M Ventures since 2009 and is crucial to the success of the healthcare fund, which he will continue to lead.”
 
Bos joined Merck KGaA’s previous biopharma fund of M Ventures in 2009 and transitioned to VP leading the healthcare team for the current fund in 2016. At M Ventures, Bos supported (among others) the early successful investments and exits in ObsEva, EpiTherapeutics (sale to Gilead), and was an initiator of Prexton Therapeutics, which was acquired early 2018 by Lundbeck for close to US$ 1.1 billion.
 
M Ventures has the mandate to invest into the four sector-focused areas: Healthcare, Life Science, Performance Materials and New Businesses. The total volume of M Ventures is €300 million in an evergreen structure. Recent investments of M Ventures include, among numerous others, Artios, Galecto, Ribometrix, CLEARink Displays, DNAScript, Mosa Meat, and Akili Interactive.
 
 

Add us as a preferred source on Google

Get the latest Ink World magazine news, insights and analysis in your Google Search and AI experiences.

Add Ink World magazine as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters

Topics